Clinical trial
LISA-study: Levothyroxin in Nodular Goiter
NCT00277589 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00277589 |
|---|---|
| Title | LISA-study : Levothyroxin in Nodular Goiter |
| Official title | TSH-adapted Therapy in a Large Randomized, Observer-blind, Placebo-controlled, Prospective Treatment Study of Patients With Nodular Goiter |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Goiter, Nodular |
| Intervention type | Drug |
| Interventions | Levothyroxin-Na, Levothyroxine-Na + iodide, Iodide, Placebo |
| Enrollment | 1,024 |
| Start date | May 1, 2004 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jan 16, 2006 |
| Last update posted | Dec 4, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: